These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24218406)

  • 1. Clinical epidemiology, diagnosis and treatment of visceral leishmaniasis in the Pokot endemic area of Uganda and Kenya.
    Mueller YK; Kolaczinski JH; Koech T; Lokwang P; Riongoita M; Velilla E; Brooker SJ; Chappuis F
    Am J Trop Med Hyg; 2014 Jan; 90(1):33-39. PubMed ID: 24218406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine profiles, blood parasite load and clinical features of visceral leishmaniasis in West Pokot County, Kenya.
    van Dijk N; Carter J; Kiptanui D; Pinelli E; Schallig H
    Parasitology; 2024 Jun; 151(7):753-761. PubMed ID: 39311405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
    Zijlstra EE; Khalil EA; Kager PA; El-Hassan AM
    Br J Dermatol; 2000 Jul; 143(1):136-43. PubMed ID: 10886148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.
    Moore E; O'Flaherty D; Heuvelmans H; Seaman J; Veeken H; de Wit S; Davidson RN
    Bull World Health Organ; 2001; 79(5):388-93. PubMed ID: 11417033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan.
    Atia AM; Mumina A; Tayler-Smith K; Boulle P; Alcoba G; Elhag MS; Alnour M; Shah S; Chappuis F; van Griensven J; Zachariah R
    Trop Med Int Health; 2015 Dec; 20(12):1674-84. PubMed ID: 26427033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of lymph node aspiration in the diagnosis of visceral leishmaniasis in Sudan.
    Babiker ZO; Davidson R; Mazinda C; Kipngetich S; Ritmeijer K
    Am J Trop Med Hyg; 2007 Apr; 76(4):689-93. PubMed ID: 17426171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing Epidemiology: A New Focus of Kala-azar at High-Altitude Garhwal Region of North India.
    Kumar Bhat N; Ahuja V; Dhar M; Ahmad S; Pandita N; Gupta V; Chandra S
    J Trop Pediatr; 2017 Apr; 63(2):104-108. PubMed ID: 27582128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leishmaniasis in Sudan. Visceral leishmaniasis.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 2001 Apr; 95 Suppl 1():S27-58. PubMed ID: 11370250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme.
    Kimutai R; Musa AM; Njoroge S; Omollo R; Alves F; Hailu A; Khalil EA; Diro E; Soipei P; Musa B; Salman K; Ritmeijer K; Chappuis F; Rashid J; Mohammed R; Jameneh A; Makonnen E; Olobo J; Okello L; Sagaki P; Strub N; Ellis S; Alvar J; Balasegaram M; Alirol E; Wasunna M
    Clin Drug Investig; 2017 Mar; 37(3):259-272. PubMed ID: 28066878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the polymerase chain reaction to assess the success of visceral leishmaniasis treatment.
    Osman OF; Oskam L; Zijlstra EE; el-Hassan AM; el-Naeim DA; Kager PA
    Trans R Soc Trop Med Hyg; 1998; 92(4):397-400. PubMed ID: 9850390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Royal Society of Tropical Medicine and Hygiene joint meeting with Médecins Sans Frontières at Manson House, London, 20 March 2003: field research in humanitarian medical programmes. Médecins Sans Frontières interventions against kala-azar in the Sudan, 1989-2003.
    Ritmeijer K; Davidson RN
    Trans R Soc Trop Med Hyg; 2003; 97(6):609-13. PubMed ID: 16134257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan.
    Mueller M; Balasegaram M; Koummuki Y; Ritmeijer K; Santana MR; Davidson R
    J Antimicrob Chemother; 2006 Oct; 58(4):811-5. PubMed ID: 16916865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence or re-emergence of visceral leishmaniasis in areas of Somalia, north-eastern Kenya, and south-eastern Ethiopia in 2000-01.
    Marlet MV; Sang DK; Ritmeijer K; Muga RO; Onsongo J; Davidson RN
    Trans R Soc Trop Med Hyg; 2003; 97(5):515-8. PubMed ID: 15307414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemic visceral leishmaniasis in southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources.
    Seaman J; Mercer AJ; Sondorp HE; Herwaldt BL
    Ann Intern Med; 1996 Apr; 124(7):664-72. PubMed ID: 8607595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.
    Burza S; Sinha PK; Mahajan R; Sanz MG; Lima MA; Mitra G; Verma N; Das P
    PLoS Negl Trop Dis; 2014; 8(1):e2611. PubMed ID: 24392171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, features and risk factors for malaria co-infections amongst visceral leishmaniasis patients from Amudat Hospital, Uganda.
    van den Bogaart E; Berkhout MM; Adams ER; Mens PF; Sentongo E; Mbulamberi DB; Straetemans M; Schallig HD; Chappuis F
    PLoS Negl Trop Dis; 2012; 6(4):e1617. PubMed ID: 22506087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.
    Singh RP; Picado A; Alam S; Hasker E; Singh SP; Ostyn B; Chappuis F; Sundar S; Boelaert M
    Trop Med Int Health; 2012 Nov; 17(11):1345-8. PubMed ID: 22882665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimony-resistant Leishmania donovaniin eastern Sudan: incidence and in vitro correlation.
    Abdo MG; Elamin WM; Khalil EA; Mukhtar MM
    East Mediterr Health J; 2003 Jul; 9(4):837-43. PubMed ID: 15748080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kala-azar: experience from a non-endemic area in India.
    Chandra J; Anand V; Patwari AK; Mandal RN; Aneja S; Sharma D
    J Trop Pediatr; 1995 Oct; 41(5):298-300. PubMed ID: 8531263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of post kala-azar dermal leishmaniasis in India.
    Tripathy K; Misra A; Mallik R; Misra D; Rout N; Rath J
    Korean J Parasitol; 2010 Sep; 48(3):245-6. PubMed ID: 20877504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.